The Institute for cancer research belongs to the Cancer Clinic situated at the Radium Hospital. The Institute comprises several divisions and this procurement is on behalf of the Division for Cancer immunology. The relevant products shall be available for the entire Oslo University Hospital organisation. The total scope of the contract is estimated to be between 2 000 — 10 000 peptides/2 years The framework agreement period is 2 years with option for further 2 years extension (1 year + 1 year).